SPH7854
/ Shanghai Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
July 04, 2026
Discovery of N-(6-Acetylpyridin-3-yl)-2-(4-(ethylsulfonyl)phenyl)acetamide derivatives as a novel series of selective RORγt antagonists.
(PubMed, Eur J Med Chem)
- "Compound 14 (SPH7854) emerged as a preclinical candidate on the basis of its potent activity and favorable drug-like properties. SPH7854 demonstrated potent activity in preclinical models of inflammatory bowel disease and has advanced to clinical trials."
Journal • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Bowel Disease • IL17A • IL23A
May 06, 2026
A Clinical Study of SPH7854 Granules in Healthy Subjects.
(clinicaltrials.gov)
- P1 | N=111 | Recruiting | Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd | Trial completion date: Dec 2025 ➔ Dec 2026 | Trial primary completion date: Dec 2025 ➔ Dec 2026
Trial completion date • Trial primary completion date • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Bowel Disease
August 13, 2024
SPH7854, a gut-limited RORγt antagonist, ameliorates TNBS-induced experimental colitis in rat.
(PubMed, Int Immunopharmacol)
- "SPH7854, especially at 15 mg/kg, significantly alleviated symptoms and improved macroscopic signs and microscopic structure in rat colitis, with decreased colonic mucosal levels of IL-17A, IL-6, tumor necrosis factor α (TNFα), monocyte chemoattractant protein-1 (MCP-1) and myeloperoxidase (MPO). These evidences indicated that blockade of RORγt activity via a gut-limited antagonist may be an effective and safe therapeutic strategy for IBD treatment."
Journal • Preclinical • Gastroenterology • Gastrointestinal Disorder • Hematological Malignancies • Immunology • Inflammatory Bowel Disease • Lymphoma • Oncology • CCL2 • CD4 • IL17A • IL6 • MPO • TNFA
July 03, 2024
A Clinical Study of SPH7854 Granules in Healthy Subjects.
(clinicaltrials.gov)
- P1 | N=111 | Recruiting | Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd
New P1 trial • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Bowel Disease
1 to 4
Of
4
Go to page
1